Question: Pegaptanib sodium injection (brand name Macugen) is an anti-angiogenic medicine for the treatment of neovascular (wet) age-related macular degeneration (AMD), it was licensed in 2000 to EyeTech Pharmaceuticals, now called what, an American pharmaceutical company based in Long Island, New York with facilities in Colorado, New Jersey and the United Kingdom?
Sentence (from "OSI Pharmaceuticals"): OSI has also made a foray into the ophthalmology market through a marketing agreement with Pfizer over Macugen (Pegaptanib) for Age-related macular degeneration; however, acquisition of the firm Eyetech, meant to provide control over this product and diversify the company, has been unsuccessful, ending in divestiture.
Relevant evidence: No